Article
Reduced catalytic activity of human CYP2C9 natural alleles for gliclazide: molecular dynamics simulation and docking studies.
Biochimie - 1 Jun 2011
Banu Hussaina, Renuka N, Vasanthakumar Geetha
Abstract excerpt
Amongst sulfonylureas, gliclazide is one of the mostly prescribed drugs to diabetic patients and is metabolized extensively by P450 CYP2C9. Among 24-CYP2C9 alleles, the *2/*2 and *3/*3 genotypes showed significantly lower gliclazide clearances with reductions of 25 and 57%, respectively. However, the reason for the change in drug-metabolizing activity induced by these natural alleles is unknown. In the present...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
